Tvardi Therapeutics, Inc.
TVRD
$27.74
$1.104.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 40.99M | 22.31M | 31.61M | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 2.14M | 1.15M | 72.00K | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 43.13M | 23.46M | 31.69M | -- | |
|
|
|||||
| Total Current Assets | 43.13M | 23.46M | 31.69M | -- | |
| Net Property, Plant & Equipment | 249.00K | 275.00K | 300.00K | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | 354.00K | 369.00K | 385.00K | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 17.00K | 3.71M | 2.83M | -- | |
| Total Assets | 43.75M | 27.81M | 35.20M | -- | |
|
|
|||||
| Total Accounts Payable | 2.43M | 1.69M | 2.19M | -- | |
| Total Accrued Expenses | 8.14M | 5.21M | 8.08M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 109.00K | 106.00K | 103.00K | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 10.68M | 7.00M | 10.37M | -- | |
|
|
|||||
| Total Current Liabilities | 10.68M | 7.00M | 10.37M | -- | |
| Long-Term Debt | -- | 35.76M | 30.26M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 145.00K | 174.00K | 201.00K | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 10.82M | 42.93M | 40.83M | -- | |
|
|
|||||
| Common Stock & APIC | 130.59M | 1.19M | 1.11M | -- | |
| Retained Earnings | -97.65M | -101.82M | -92.24M | -- | |
| Treasury Stock & Other | -13.00K | 2.00K | -- | -- | |
| Total Common Equity | 32.93M | -100.63M | -91.13M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | 85.50M | 85.50M | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | 85.50M | 85.50M | -- | |
|
|
|||||
| Total Common Equity | 32.93M | -100.63M | -91.13M | -- | |
| Total Preferred Equity | -- | 85.50M | 85.50M | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 32.93M | -15.12M | -5.63M | -- | |
|
|
|||||